A new small-molecule kinase inhibitor for airway disease
Ended Project Grant Awarded Last action
- Award ID
- R41HL149523
- Recipient
-
Nupeak Therapeutics Inc. UEI KLCRCAQBG417
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- Missouri, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $300,000 |
Quick answers
Who received award R41HL149523?
R41HL149523 was awarded to Nupeak Therapeutics Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on August 7, 2019.
How much is award R41HL149523 worth?
$300,000 has been obligated on R41HL149523.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award